Sibutramine improves insulin sensitivity and reduces bodyweight in obese patients with type 2 diabetes mellitus

By  

Inpharma, Vol. 1, Iss. 1507, 2005-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Rosiglitazone may increase the risk of chronic heart failure (HF) in patients receiving insulin for type 2 diabetes mellitus

By  

Reactions Weekly, Vol. 1, Iss. 1030, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Retrospective Analysis of Rosiglitazone and Macular Oedema in Patients with Type 2 Diabetes Mellitus

By Tatti Patrizio  

Clinical Drug Investigation, Vol. 28, Iss. 5, 2008-01 ,pp. : 327-332

Adis International

Access to resources Recommend Favorite

An Olmesartan Medoxomil-Based Treatment Algorithm is Effective in Achieving 24-Hour BP Control in Patients with Type 2 Diabetes Mellitus, Regardless of Age, Race, Sex, or Severity of Hypertension: Subgroup Analysis of the BENIFICIARY Study

By Neutel Joel M.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 5, 2010-10 ,pp. : 289-303

Adis International

Access to resources Recommend Favorite

Valsartan Increases Circulating Adiponectin Levels without Changing HOMA-IR in Patients with Type 2 Diabetes Mellitus and Hypertension

By Lee J-M   Kim J-H   Son H-S   Hong E-G   Yu J-M   Han K-A   Min K-W   Chang S-A  

The Journal of International Medical Research, Vol. 38, Iss. 1, 2010-01 ,pp. : 234-241

Field House Publishing

Access to resources Recommend Favorite